The authors show that the inhibitor of the succi nate dehydrogenase, 3-nitroproprionic acid (3-NPA), which in high doses and with chronic administration is a neurotoxin, can induce profound tolerance to focal cerebral ischemia in the rat when administered in a single dose (20 mg/kg) 3 days before ischemia. Infarcts were approximately 70% and 35% smaller in the 3-NPA preconditioned groups of permanent and transient focal cerebral ischemia, respectively. This regimen of 3-NPA preconditioningf neither induced necrosis, apoptosis, or any other histologically detectable damage to the brain, nor did it affect behavior of the animals. 3-NPA led to an immediate (I-hour) and long-lasting (3-day) decrease in succinate dehy drogenase activity (30% reduction) throughout the brain, whereas only a short metabolic impairment occurred (ATP de crease of 35% within 30 minutes, recovery within 2 hours). The authors found that 3-NPA induces a burst of reactive oxygen species and the free radical scavenger dimethylthiourea, when Abbreviations used: 3-NPA, 3-Nitroproprionic acid; CCAIMCAO, common carotid artery and middle cerebral artery occlusion; CHX, cycloheximide; DMTU, dimethyl thiourea; LDF, laser-Doppler t1ow
In many organs a short ischemic interval, in itself not sufficient to cause tissue damage, induces tolerance to more severe and prolonged reductions in organ perfu sion: ischemic preconditioning. Clinical applications of ischemic preconditioning have already successfully been tested in cardiology. Ischemic preconditioning also exists in the brain, but no clinically applicable protocols have administered shortly before the 3-NPA stimulus, completely blocked preconditioning. Inhibition of protein synthesis with cycloheximide given at the time of 3-NPA administration com pletely inhibited preconditioning. The authors were unsuccess ful in showing upregulation of mRNA for the manganese su peroxide dismutase, and did not detect increased activities of the copper-zinc and manganese superoxide dismutases, proto typical oxygen free radicals scavenging enzymes, after 3-NPA preconditioning. The authors conclude that it is possible to pharmacologically precondition the brain against focal cerebral ischemia, a strategy that may in principal have clinical rel evance. The data show the relevance of protein synthesis for tolerance, and suggests that oxygen free radicals may be critical signals in preconditioning. Key Words: 3-nitropropionic acid-Oxygen free radicals-Preconditioning-Rat Succinate dehydrogenase-Superoxide dysmutase. emerged and mechanisms have remained enigmatic. In addition to ischemia itself, other stimuli may afford tol erance to cerebral ischemia, e.g., repeated spreading de pressions, cytokines, inflammatory stimuli such as lipo polysaccharide , or inhibition of the succinate dehydro genase (SDH) (Prass et ai., 1998) . Ischemic tolerance is induced in many cell types by a number of different stimuli, however, tolerance may be triggered and ex ecuted by common mechanisms (Hochachka et ai., 1996) . A review of the literature suggests that the gen eration of oxygen free radicals (OFR) may represent such a common trigger (Schumann et ai., 1999) .
3-Nitropropionic acid (3-NPA), an irreversible inhibi tor of the SDH (Hassel and Sonnewald, 1995) located in the tricarboxylic acid cycle and in complex II (SDH, cytochrome b) in the oxidative phosphorylation, induces OFR formation (Beal et ai., 1995) . It can generate toler ance to hypoxia in in vitro models of cerebral ischemia (Riepe et ai., 1997) , as well as against global cerebral ischemia in vivo (Nakase et aI., 1997; Sugino et aI., 1999) . We here describe for the first time that a single dose of 3-NPA given intraperitoneally induces profound tolerance to permanent or transient cerebral ischemia in the rat, without producing tissue damage. It is shown that 3-NPA, while transiently decreasing SDH activity and energy rich phosphates, leads to a burst of OFR, and that the inhibition of OFR formation or protein synthesis completely blocks preconditioning. We speculate that a pharmacologic mode of preconditioning, as shown here, may have clinical relevance and that 3-NPA induced tolerance represents an attractive model to investigate endogenous protective mechanisms of the brain.
METHODS
All 161 animals used in this study were treated in accordance with the Guidelines fo r the use of Animals in Neuroscience Research of the Society for Neuroscience. NPA-and drug pretreatment was performed by intraperitoneal injection (pH 7.4). There where no major differences in anesthesia, recording of physiologic data, and methods used for brain extraction be tween groups. All surgical and treatment procedures were per fonned in one series by the same surgeon in a randomized fashion.
Focal cerebral ischemia f In male Wistar rats (250 to 300 g) the right ipsilateral common carotid artery (CCA) and the middle cerebral artery (MCA) were permanently or transiently (90 minutes of isch emia) occluded (CCAfMCAO) under halothane anesthesia as described by Brint et al. (1988) . In addition to the right CCA the left CCA was temporarily occluded for I hour (90 minutes in the reperfusion group). Animals were killed 4 days after CCAfMCAO.
Physiologic monitoring
In all animals mean arterial blood pressure was monitored continuously throughout anesthesia through a tail artery cath eter, while rectal temperature was measured and maintained at 38° ± 0.5°C with a heating pad. In some of the animals tem perature of the left temporal muscle as a measure of brain temperature was monitored with a needle thermometer. After surgery rectal temperature was measured daily in all animals. In six animals temperature during the 3-NPA pretreatment period was determined (time points after 3-NPA application: 30 min utes and then 1, 2, 4, 6, and 24 hours and daily up to 7 days).
During surgery blood gas analysis (arterial oxygen and carbon dioxide tensions, pH, base excess) was performed every 30 minutes. Blood glucose was measured directly before MCAO (arterial) and on the first day after surgery (tail vein) in all. In six animals venous blood glucose was measured before, 1 hour, and 24 hours after 3-NPA injection. Hematocrit was deter mined 24 hours after MCAO in every animal.
In some experiments, laser Doppler flowmetry (LDF, Perimed Periflux Master 4001 with PF 403 probe, Jarfalla, Sweden) was used to quantify the consequences of CCAI MCAO on regional cerebral blood flow (rCBF) in the MCA territory. The skull bone was thinned to translucency and the LDF probe was placed 2 mm lateral and 3 mm caudal to the bregma over a region assumed to represent the evolving infarct core.
J Cereb Blood Flow Metab, Vol. 19, No. 11, 1999 Histology To assess possible brain damage by 3-NPA, three animals were killed 3 days after 3-NPA injection (20 mg/kg). After transcardial perfusion, brains were removed from the skull, fixed, and prepared for standard paraffin embedding. Serial coronal sections (20 J.1m) throughout the entire brain were cut using a microtome (HM330, Microm, Heidelberg, Germany).
After hematoxilin/eosin or Nissl staining of adjacent sections, slides were examined using light microscopy.
DNA gel electrophoresis
We performed gel electrophoresis of brain extracts 3 days after 3-NPA injection by a commercial DNA isolation kit and a radioactive Phosphor labeling with the aid of a Phosphorim ager (Molecular Dynamics, CAl on three animals. For detailed methods see Bruer et al. (1997) .
Quantitative infarct volume analysis
Four days after focal cerebral ischemia the animals were reanesthetized with halothane and decapitated. The brains were rapidly removed and frozen in 2-Methylbutan (Carl Roth GmbH, Karlsruhe, Germany) at -30° C. Coronal brain sections (40 J.1m) were cut serially at 400 J.1m intervals with a cryotome (HM 500 OM, Microm, Heidelberg, Germany) at -2SO C, dried over night and stained with vanadium acidic fuchsin (Victorov and Barskov, 1993) . Infarct volumes were calculated from 30 to 35 coronal sections by an observer blinded to the treatment groups using an image analysis system. Because the brains were obtained 4 or 7 days after the CCA/MCAO, time points when ischemic brain edema has subsided, no correction for brain swelling was necessary (Lin et aI., 1993) . 
A TP measurements

Succinate dehydrogenase activity measurements
One hour and then 1, 3, 5, and 7 days after 3-NPA injection animals (two per time point) were decapitated in deep anesthe sia. The brains were rapidly removed, quickly frozen in 2-Methylbutan at -30°C, stored at -80°C until coronal sections (40-J.1m thick) were cut serially at 400-J.1m intervals at -20°e.
For imaging of SDH activity on brain sections we used a his toblot technique. Sections were mounted on nitrocellulose membranes (Biometra, Goettingen, Germany) and fixed by drying for 30 minutes at 4°e.
The nitrocellulose histoblots with the immobilized brain slices were stained in 50 mmollL Tris/HCl (pH=7.4), 10 mmollL succinate, and 0. 5 mmollL tetranitroblue tetrazolium for 10 minutes at room temperature. Afterward slices were fixed with 1 mollL HCl, rinsed with phosphate-buffered saline solution and air dried. Succinate dehydrogenase activities for three different brain regions (cortex, striatum, hippocampus) were densitometrically quantified in serial brain sections (40 J.1m) at I-mm intervals.
Photometric determination of SDH activity was performed in 50 mmol/L Tris/HCl (pH = 7.4), 25 mmol/L sucrose, 50 f.LmoIlL 2,6-dichloroindophenol, and 10 mmoIlL succinate at 604 nm and 25°C after homogenization of brain slices. Protein content of the samples was measured according to Bradford (1976) .
Chemiluminescence measurement of reactive oxygen species in acute brain slices subjected to 3-NPA To evaluate whether 3-NPA induces the generation of reac tive oxygen species (ROS), a lucigenin-enhanced chemilumi nescence technique, which is especially sensitive to superoxide anion radicals, was used (Dirnagl et aI., 1995) . Acute vibratome brain slices (400 /-Lm) were prepared, equilibrated at room tem perature (30 minutes) and then maintained for 90 minutes at 34°C. Afterward slices where transferred into a recirculation system with a submerged chamber perfused with Krebs Henseleit-buffer at 34°C and at a p02 > 500 mm Hg. Lucigenin Detection by the Gene Images system (Amersham) was per formed as recommended by the manufacturer.
Measurement of 3-NPA induced cerebral CU/Zn and Mn-SOD activity
After 3-NPA treatment rats were rapidly decapitated in deep anesthesia after 1 hour and after I, 3, 5, and 7 days. Cortical tissue samples were dissected out rapidly from the removed brain over ice (approximately 50/-LL each). Brain tissue was immediately frozen in liquid nitrogen and stored at -80°C until SOD measurement. The activities of Cu/Zn-and Mn-SOD, respectively, were determined by direct photometric measure ment of the superoxide anion according to the method of Bo lann et al. with minor modifications (Bolann and UI vik, 1991; Bolann et aI., 1996) . The decrease of superoxide anion was directly monitored photometrically at 250 nm, 4°C, and pH = 9.5. Mn-SOD activity was distinguished from Cu/Zn-SOD by addition of 10 mmoIIL KCN. Three animals were used in each group. Activity of Cu/Zn-SOD was calculated as units per mil ligram of protein according to Marklund (1976) and Bolann and Ulvik (1991) where one unit is defined as the activity which is sufficient to achieve a pseudo-first -order rate constant of 0.1 S-l in 1 mL sample volume. One hundred percent ac tivity of Cu/Zn-SOD from rat brain cortex lysate corresponded to 41.7 units/mg protein. V max activity of Mn-SOD was calcu lated as /-LMol mL x min x mg protein'
One hundred percent activity of Mn-SOD from rat brain cortex lysate corresponded to 17. 3 L'
. m x mm x mg protem
Statistical analysis
All data are reported as mean values ± SD. Multiple com parisons between groups (infarct volumes, physiologic vari ables, rCBF) were made using analysis of variance with Bon ferroni's post hoc comparison (SPSS Inc. Chicago IL). P values of .05 were considered statistically significant.
Drugs
All drugs, unless otherwise noted, were purchased from Sigma Chemicals (Deisenhofen, Germany).
RESULTS
3-NPA induces tolerance to focal cerebral ischemia without producing tissue damage
Single dose intraperitoneal treatment with 3-NPA in duced strong protection (73% reduction compared to the control group, P < .05) against subsequent permanent focal cerebral ischemia only when given 3 days before induction of cerebral ischemia. The 3-day pretreatment group was also significantly different to the 12-hour, 2-day, and 7-day pretreatment groups (Fig. 1 ). For all further experiments we chose the 3-day preconditioning interval. In the transient focal cerebral ischemia experi ments, 3-NPA pretreatment reduced infarct sizes from 145 ± 26 mm 3 (n=9) to 93 ± 41 mm 3 (n= 10, 35% reduction, P < .01). Three days after intraperitoneal injection of a single dose of 3-NPA (20 mg/kg), brains did not show any evidence for cell damage on light microscopical exami nation in any brain region. No evidence for DNA strand breaks indicative of apoptosis were found on DNA gel electrophoresis. Within the first 3 hours after 3-NPA ad ministration (period of mild acidosis) animals slightly hyperventilated and showed depressed motor activity. No signs of delayed movement impairment (e.g., hyper activity or hypoactivity, ventral or lateral recumbency, as noted after chronic 3-NPA treatment) (Borlongan et aI., 1995) was detected during the 7 -day observation period.
Physiologic data. Treatment with 20 mg/kg 3-NPA led to a short and mild decrease in arterial blood pH 45 minutes after injection (blood pH minimum at about 7.30) in rats anesthetized with halothane for monitoring purposes, which normalized within 20 minutes. Rectal temperature measurements and blood glucose measure ments directly after 3-NPA injection and during the en tire 7-day observation period revealed no differences in preconditi«med compared to control rats.
During surgery physiologic parameters of control and preconditioned animals showed no statistically signifi cant differences (Table 1) . Animals treated with cyclo heximide (CHX) or dimethylthiourea (DMTU) (data not shown) showed no significant differences in physiologic variables. Common carotid artery/middle cerebral artery occlusion decreased temperature in the ipsilateral M. temporalis by about 10 C in all animals, without differ ences between experimental groups. Because of a stress response during surgery all animals showed increased blood glucose levels, which normalized when controlled 24 hours later (no differences in between groups). The increased hematocrit found in all animals 24 hours after CCAIMCAO is most likely due to reduced water uptake after surgery (Table I) .
LDF measurements of rCBF were performed to test whether 3-NPA pretreatment may have affected the se verity of ischemia or extent of reperfusion. No differ ences between control rats and preconditioned animals (3-day 3-NPA) were found, neither in the permanent, nor in the transient ischemia group. In the permanent occlu sion group during CCA/MCAO the rCBF of control and preconditioned animals decreased to l3 ± 6% and 13 ± 7%, respectively. After reopening of the temporary con tralateral CCA occlusion rCBF slightly increased to 33 ± 10% and 19 ± 3% (control versus preconditioned; not Values are mean ± SD. CCA. common carotid artery; CHX. cycloheximide; Glue, glucose; HCT, hematocrit; MCAO, middle cerebral artery occlusion; NPA, nitroproprionic acid; SAP, systemic arterial pressure. significant). In the transient ischemia group, rCBF de creased to 11 ± 1% (control) and 12 ± 5% (precondi tioned). During the first 15 minutes of reperfusion, rCBF increased to 88 ± 24% (control) and 87 ± 22% (precon ditioned).
Spatial distribution and time profile of cerebral succinate dehydrogenase inhibition by 3-NPA Succinate dehydrogenase activity decreased to about 70% 1 hour after 3-NPA application. Thereafter SDH activity slowly recovered within 7 days. No significant difference between the various gray matter regions was detected. Quantitative, photometric measurements of brain section homogenates highly corresponded to the densitometrically determined SDH activities (Fig. 2) .
Measurement of energy-rich phosphates
ATP values decreased about 35% within the first 30 minutes after intraperitoneal 3-NPA injection (Fig. 3) . Control values in nmol/mg protein: ATP 29.9 ± 5.5, ADP 10.8 ± 1.7, AMP 3.1 ± 0.1. This ATP decrease was accompanied by a two-fold increase of ADP and a 40% increase of AMP and coincided with the point when mild blood acidosis was measured (see above). ATP levels recovered fast and reached control values 2 hours after 3-NPA injection. Guanosinphosphates (control values in nmol/mg prQtein: GTP 4.7 ± 0.8, GDP 2.6 ± 0.2, GMP O.5± 0.08) showed similar kinetics, with a 33% decrease in GTP accompanied by an increase in GDP and GMP (Fig. 3) .
3-NPA induces reactive oxygen species generation
Superfusion of 3-NPA (300fLmollL) onto acute brain slices led to a significant rise in photon counts in luci genin-enhanced chemiluminescence, indicating a burst of OFR. Increased photon counts were detected already 1 hour after the 3-NPA challenge and reached a maximum 2 hours later. Thereafter, photon counts decreased and control values were reached within the next 2 hours (Fig.  4) . During the 4-hour observation period 3-NPA treated slices (n = 6) showed an integral of 61,546 ± 27,808 photon counts in 4 hours, whereas untreated slices showed only an integral of 14,872 ± 8,093 counts in 4 hours (n = 11, P < .001).
Inhibition of oxygen free radicals production blocks tolerance induction
The ROS scavenger DMTU (especially effective in scavenging hydroxyl radicals), administered 30 minutes before 3-NPA, led to infarct volumes (176 ± 42 mm 3 ) Typical chemiluminescence recording of an acute brain slice, superfused with a perfusion medium containing the chemi luminescence enhancer lucigenin. After an equilibrium period 3-nitroproprionic acid (3-NPA) was added to the perfusion me dium (arrow) in a dose equivalent to the in vivo experiments (300 IJmoIlL). Emitted photons were counted as marker for the gen eration of reactive oxygen species, revealing a burst in reactive oxygen species production. Photons were counted in 6-second intervals.
which were not statistically significantly different from control animals which had not received 3-NPA precon ditioning. DMTU alone, given 3 days in advance to CCAIMCAO had no effect on infarct volumes (142 ± 51 mm 3 ) ( Fig. 5 ).
Protein synthesis inhibition blocks tolerance induction
The unspecific protein synthesis inhibitor CHX (1 mg/ kg intraperitoneally) administered 30 minutes before 3-NPA treatment resulted in infarct volumes (116 ± 32 mm 3 ) identical to control animals without precondition ing. Cycloheximide alone (i.e., without 3-NPA), given 3 days in advance to CCAIMCAO, had no effect on infarct volumes (102 ± 55 mm 3 ) (Fig. 5 ).
3-NPA did not induce Mn-SOD mRNA, nor brain
CulZn-SOD or Mn-SOD activity
Northern blotting SOD did not show any significant regulation of cortical Mn-SOD mRNA expression 6, 13, 24 or 72 hours after intraperitoneal injection of 20 mg/kg 3-NPA (Fig. 6 ). To determine SOD activity, cortical tis sue samples from different animals were collected at 1 hour, 24 hours, 3 days, 5 days, and 7 days after the 3-NPA challenge. Significant changes in mitochondrial Mn-SOD, or cytosolic CulZn-SOD activity were not de tected (Table<-2). 3-Nitroproprionic acid (3-NPA) induced tolerance to focal cerebral ischemia can be blocked by co-application of cyclohex imide (CHX) or the free radical scavenger dimethylthiourea (DMTU), when administered 30 minutes before 3-NPA precondi tioning 3 days prior to the focal cerebral ischemia. CHX or DMTU alone administered at the same time point showed no effect on infarct volume. Number of animals given in brackets. Data given as mean ± SO. 'Denotes significant difference to 3-NPA, P < 0.05. emia using an inhibitor of the oxidative phosphorylation. 3-NPA pretreatment 3 days before induction of focal cerebral ischemia reduced infarct volumes by 73% (per manent ischemia) or 35%, respectively (transient isch emia). Compared with other models of induced ischemic tolerance in the brain, 3-NPA induces the highest degree of protection shown so far. We can only speculate why protection in permanent focal cerebral ischemia was more pronounced.
It is widely accepted that reperfusion, despite its po tentially beneficial effects, may also challenge the isch emic tissue. Oxygen free radicals, invasion of activated leukocytes, or plasma extravasation have been impli cated in this so-called reperfusion paradox. Precondi tioned neurons may thus be overwhelmed by mecha nisms of damage activated by reperfusion.
The preconditioning dose of 3-NPA did not generate any detectable parenchymal damage, as shown by stan dard light microscopy, nor did it produce apoptosis or neurological abnormalities. This is in accordance with a study by Alexi et aI. (1998) , in which rats receiving a single dose of 20 mg/kg intraperitoneally did not show any signs of brain damage. In contrast, repeated low doses of 3-NPA induce selective striatal cell loss in ani mals (Beal et aI., 1993) , and high concentrations of 3-NP A have been shown to induce apoptotic cell death of neurons in vitro (Behrens et aI., 1995) .
We found that development of tolerance was a time consuming process. Statistically significant protection was only seen 3 days after 3-NPA. A preconditioning interval of 2 days was not sufficient to generate toler ance, nor was a 5-day interval (Fig. 1) .
In the brain this temporal pattern of tolerance induc tion is a consistent finding regardless of the precondi tioning stimulus (Prass et aI., 1998) . Usually maximum Per time point 3 animals were studied. Each value was determined at least 5 times. Control values were set to 100%. Values are mean ± SD. One hundred percent activity of Cu/Zn-SOD from rat brain cortex lysate corresponded to 41.7 units/mg protein. One hundered percent activity of Mn-SOD from rat brain cortex lysate corresponded to 17.3 �mol/mL x min x mg protein.
Cu/Zn-SOD, Copper-superoxide dysmutase; Mn-SOD, manganese superoxide dysmutase.
protection can be found 2 to 5 days after tissue challenge, whereas tolerance disappears 7 days after the stimulus. A narrow time window of tolerance induction was found in a recent study in which maximum protection was in duced by 3-NPA intraperitoneally 3 days before induc tion of global cerebral ischemia in the gerbil (Sugino et aI., 1999) , which is in good agreement with our findings. Histologic infarct evaluation was performed 4 days after induction of focal cerebral ischemia, a time point when in this model the infarct has fully matured. How ever, it cannot be ruled out that 3-NPA may only have delayed infarction. Although unlikely, future studies must investigate even longer survival times (>2 weeks).
From our data it can be safely concluded that the pre conditioning effect of 3-NPA is not caused by effects on body or brain temperature, blood glucose, or other physi ologic variables. The fact that CBF changes during isch emia and reperfusion where not different in precondi tioned versus untreated animals argues against an in volvement of rCBF in preconditioning. Since LDF does not measure absolute rCBF, it might be argued that an increase in baseline rCBF may have escaped our inves tigation. However, delayed effects on rCBF have not been reported. In addition, we have preliminary evidence that 3-NPA also preconditions purified cortical neurons in culture against oxygen glucose deprivation (data not shown), strengthening the notion that development of tolerance is independent of hemodynamic effects.
3-NPA effects on energy metabolism
3-NPA is a suicide inhibitor of the SDH. In eucary ontic cells, SDH is present as complex II in oxidative phosphorylation and in the tricarboxylic acid cycle. Sys temic administration of 20 mg/kg led to SDH inhibition by about 30% within 1 hour, which is in agreement with the literature (Alexi et aI., 1998) . Succinate dehydroge nase activity regeneration was a rather slow process, full SDH activity was not regained until the day 7 (Fig. 2) .
Succinate dehydrogenase inhibition by 3-NPA de creased ATP and GTP to a minimum of about 35% of the normal levels in the first 30 minutes, which is in accor dance to in vitro findings of Erecinska and Nelson (1994) , and recovered within 2 hours. This degree of metabolic inhibition was not associated with tissue dam-age. Inhibition of oxidative phosphorylation induces nonaerobic glycolysis and, therefore, production of lac tate. Other groups showed an increase in lactate produc tion within the first 3 hours after 3-NPA application in cell culture (Zeevalk et aI., 1995) and in vivo (Jenkins et aI., 1996) , which is consistent with the time pattern found in our study.
Metabolic impairment may be responsible for neuro nal damage by high doses of 3-NPA (Brouillet et aI., 1995) . Recent data shows that the type of neuronal death induced by 3-NPA is dose-dependent (Pang and Geddes, 1997) . In rat hippocampal cell cultures and in vivo inter mediate doses of 3-NPA clearly induced apoptosis (Sato et aI., 1997) , whereas high doses led to NMDA-receptor dependent excitotoxic cell death. In the low concentra tion used here ATP depletion does not produce neuronal necrosis, nor apoptosis, as shown. We therefore specu late that 3-NP A, dependent on its concentration, can in duce three different cellular responses: tolerance, apop tosis, or excitotoxic cell necrosis.
It is well established that reductions in energy metabo lism (e.g., by hypothermia) are neuroprotective. One might therefore speculate that low doses of 3-NPA gen erate their neuroprotective effect simply by inhibiting cellular energy metabolism. However, for the following reasons we believe that this is unlikely: (1) Maximum SDH and ATP inhibition are already present 1 hour after 3-NPA application, a time point at which no significant protection was found. (2) Development of tolerance was a time-consuming process, with maximum protection when SDH inhibition and the decrease in energy rich phosphates was already recovering. (3) Inhibition of pro tein synthesis abolished preconditioning (see below). We conclude that impairment of the mitochondrial electron transport chain and the consecutive short impairment of energy production are not the primary cause, but rather the trigger for the induction of ischemic tolerance.
Cycloheximide, a protein synthesis inhibitor, prevents tolerance induction by 3-NPA Independently of the stimulus used to induce tolerance against ischemia in the brain, the interval to maximum protection is between 24 and 72 hours (Prass et aI., 1998) . It is generally assumed that the neosynthesis of protective proteins is responsible for the delay in toler ance development. This is in line with our data because protein synthesis inhibition with CHX completely abol ished 3-NPA preconditioning.
Cycloheximide itself protects against focal cerebral ischemia when given immediately before induction of focal cerebral ischemia (Kharlamov et aI., 1997) . Cyclo heximide also has the capacity to protect cultured striatal and cortical neurons against the toxicity of 3-NPA (Beh rens et aI., 1995) . These effects where mainly attributed to a CHX-induced blockade of apoptosis (Du et aI., 1996) because apoptotic cell degeneration depends on intact protein synthesis. In rats CHX doses higher than 0.6 mg/kg are known to reduce brain protein synthesis for at least 24 hours (Pavlik and Teisinger, 1980) . How ever, recent in vitro findings indicate that CHX, when given in low doses, besides inhibiting protein synthesis also acts as a potent inductor of neuroprotective proteins, such as bcl-2 and antioxidants (Furukawa et aI., 1997) . One might speculate that an early induction of free radi cal scavengers would have decreased the potential of 3-NPA to induce tolerance, not by inhibition of protein synthesis, but rather by diminishing the 3-NPA induced free radical burst which is essential for an efficient tol erance induction. The fact that the time interval between CHX and 3-NPA application was rather short (30 min utes) argues against this speculation, the induction of protective proteins by CHX takes several hours (Fu rukawa et aI., 1997) . However, we cannot rule out that other mechanisms than protein synthesis inhibition may have contributed to the CHX induced blockade of toler ance induction.
Involvement of free radicals in tolerance induction
Inhibition of mitochondrial respiration generates ROS formation (Garcia-Ruiz et aI., 1995) . We therefore spec ulated that ROS formation caused by 3-NPA might criti cally contribute to tolerance induction. With lucigenin enhanced chemiluminescence, an assay particularly sen sitive to superoxide anion, in acute brain slices we detected a burst of ROS induced by 3-NPA. Other stud ies have produced additional evidence for 3-NPA induced oxidative stress (Beal et aI., 1995; Fu et aI., 1995) . Further proof for the critical involvement of free radicals in the cascade of tolerance development is given by the fact that pretreatment with the free radical scav enger DMTU completely abolished tolerance induction (Fig. 5) .
Biological tissues react to oxidative stress with the induction of ROS scavenging enzymes. It is well known that ROS scavengers protect the brain against various types of ischemia. Thus, it was tempting to speculate that it is the induction of these protective proteins which pro tect the brain after 3-NPA preconditioning. Superoxide dismutase isoforms were shown to be induced by pre-J Cereb Blood Flow Metab, Vol. 19, No.1 I, 1999 conditioning in several models of global cerebral (Kato et aI., 1995) and myocardial ischemia (Steeves et aI., 1994) . 3-NPA neurotoxicity is attenuated in Cu/Zn-SOD transgenic mice (Beal et aI., 1995) . However, we found no evidence for changes in Cu/Zn-SOD or Mn-SOD ac tivity, nor did we detect changes in Mn-SOD mRNA at any time point studied. This is in accordance with other studies which showed no changes in brain SOD content after up to 40 mg/kg 3-NPA (Fu et aI., 1995; Prapurna et aI., 1996) . Our data therefore argues against the involve ment of SOD in tolerance induction in our model. How ever, it does not exclude that other inducible OFR scav enging systems may have been involved, such as cata lase, glutathion, ascorbic acid, tocopherols, uric acid, melatonin, or histidine related compounds.
Besides OFR scavengers, other potential protein can didates to explain 3-NPA induced tolerance have to be considered: antiapoptotic proteins such as bcl-2, bcl-x long, neuronal apoptosis inhibitory protein (NAIP), heat shock proteins, and neurotrophic factors such as BDNF, among others.
CONCLUSION
The neosynthesis of thus far unknown protective pro teins is responsible for profound ischemic tolerance in duced by 3-NPA. It is likely that the formation of OFR is involved in this process, but SOD is not responsible for protection. Further research is needed to pinpoint the protective proteins. In contrast to previously described preconditioning protocols, strategies like the one de scribed here may lead to clinically applicable, pharma cologic strategies to protect the brain against focal isch emia. In any event, 3-NPA preconditioning presents an unique model to study cellular responses to metabolic stress and the induction of endogenous, protective pro grams.
